ACADIA PHARMACEUTICALS INC Quarterly Costs and Expenses in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2015 to Q2 2024.
  • Acadia Pharmaceuticals Inc Costs and Expenses for the quarter ending June 30, 2024 was $212M, a 30.4% increase year-over-year.
  • Acadia Pharmaceuticals Inc Costs and Expenses for the twelve months ending June 30, 2024 was $868M, a 27.9% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Costs and Expenses for 2023 was $800M, a 7.96% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Costs and Expenses for 2022 was $741M, a 13.2% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Costs and Expenses for 2021 was $655M, a 10.1% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $868M $212M +$49.3M +30.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $818M $191M +$18.6M +10.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $800M $196M +$13.5M +7.42% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $786M $269M +$108M +66.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $678M $162M -$6.02M -3.58% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $684M $172M -$56.4M -24.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $741M $183M +$7.14M +4.07% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $734M $162M +$14.7M +9.98% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $719M $168M +$9.28M +5.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $710M $228M +$55.2M +31.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $655M $175M -$12.8M -6.78% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $667M $147M -$59.6M -28.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $727M $159M +$4.82M +3.13% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $722M $173M -$6.26M -3.48% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $728M $188M +$33.4M +21.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $695M $206M +$66.5M +47.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $628M $154M +$13.8M +9.85% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $615M $180M +$29M +19.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $586M $155M +$27.9M +22% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $558M $140M +$20.4M +17.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $537M $140M +$19.2M +15.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $518M $151M +$46.9M +45.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $471M $127M +$13.3M +11.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $458M $120M +$18.4M +18.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $440M $121M +$22.6M +23% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $417M $104M -$320K -0.31% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $417M $114M +$23.4M +25.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $394M $101M +$23.6M +30.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $370M $98.5M +$26.5M +36.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $344M $104M +$53.7M +107% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $290M $90.2M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $77.7M +$38.6M +99% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $72M +$32.5M +82.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $50.3M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $39M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $39.5M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.